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Pitfalls in the Diagnosis of
Latex Allergy
Sujoy Khan1,2, Steve Holding2,3, Philip Doré2,4 and Carrock Sewell1,4
ABSTRACT
Background: Screening patients for latex allergy prior to surgery is an important but intensive procedure. The
appropriate testing strategy for diagnosing latex (Hevea brasiliensis) allergy involves in-vitro specific IgE or skin
prick testing. The sensitivity and specificity of both tests are influenced by patient-specific factors or manufac-
turing processes that alter the clinically relevant allergens in skin testing solutions.
Methods: Total IgE and latex-specific IgE testing was introduced as a screening test. Skin prick testing was
done on patients with a high probability of latex allergy and negative specific IgE with total IgE <100 kUL.
SDS-PAGE was done on the non-ammoniated latex (NAL) and newly introduced ammoniated latex (AL) re-
agents for the clinically relevant allergens.
Results: 51 patients had a total IgE <100 (range, 2.8-99.0 kUL), and 10% had a positive skin test. 60% of
positive skin tests would have been missed with lower total IgE cut-offs of 50 kUL (6% of referrals). SDS-
PAGE of the NAL solution showed 3 prominent bands with molecular weights of approximately 20, 24 and 42
kDa that correlated with Hev b 6, Hev b 3 and Hev b 713, respectively. In contrast, the AL solution showed 3
very faint higher molecular weights bands that did not correlate with clinically relevant antigens.
Conclusions: Increasing the cut-off value of total IgE for allergen-specific IgE testing increased the sensitivity
of the specific IgE test. The NAL reagent had a greater number of clinically significant allergens at higher con-
centrations than AL, which may have implications for the clinical sensitivity of the newer AL reagent.
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ABBREVIATIONS
IgE, immunoglobulin E; SPT, skin prick testing; NAL, non-ammoniated latex; AL, ammoniated latex; HEP, hista-
mine equivalence prick; SDS-PAGE, sodium-dodecyl sulphate polyacrylamide gel electrophoresis; MW, mo-
lecular weight; IUIS, International Union of Immunological Societies.
INTRODUCTION
Allergy to natural rubber latex is being increasingly
recognized with important implications. While <1% of
the general population is considered to be sensitized
to latex, the figure rises to 17% in health care work-
ers.1 IgE tests are an alternative to skin tests in the di-
agnosis of type 1 hypersensitivity reactions,2 and pre-
operative screening for latex allergy accounts for a
substantial workload in our practice. Challenge tests
with latex are usually performed in cases negative for
both specific IgE and skin prick tests in patients with
high prior probability of latex allergy. However, many
questions remain unanswered in the in-vitro and skin
testing strategies used for the diagnosis of latex al-
lergy. We tried to address these questions in our co-
hort of patients referred from various departments for
the diagnosis of latex allergy.
Is there a level of total IgE below which latex spe-
cific IgE becomes insensitive? Which latex skin test-
ing solution, non-ammoniated latex [NAL] or the
newly introduced ammoniated latex [AL] should be
used for clinical diagnosis of latex allergy?
Following the replacement of NAL with AL re-
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Table 1 The clinical symptoms and skin test results of patients with latex alergy
Latex SPT
NAL solution
weal (mm)
Specific
IgE
Total
IgEClinical symptomsPatient
1 HEP 4 mmNegative41Urticaria, angioedema, rhinitis (exposure to baloons)1
10 HEP 4 mmNegative65Urticaria & angioedema (rubber gloves), reaction to condoms2
100 HEP 2 mm
Significant flare; itching++
Negative79Reaction to condoms; lip angioedema (on exposure to bal
loons, eating peaches and watermelon)
3
10 HEP 4 mmNegative82Urticaria (contact with rubber)4
10 HEP 4 mmNegative31Urticaria & angioedema (rubber gloves), reaction to condoms5
Table 2 Analysis of various total IgE cut-ofs
Number
needed to
test
% of referals
with missed
positive SPT
% of positive SPT
missed
Total IgE
cut-of
(IU/ml)
100% (0/51) 0% (0/5)100
 90% (0/51) 0% (0/5) 90
112% (1/51)20% (1/5) 80
144% (2/51)40% (2/5) 70
196% (3/51)60% (3/5) 60
176% (3/51)60% (3/5) 50
agents for skin prick testing (SPT) we observed a fall
in the incidence of positive reactions. This was inves-
tigated by parallel SDS-PAGE of the old (NAL) and
new (AL) SPT reagents to determine if the relevant
proteins were present in both solutions.
METHODS
PATIENT SELECTION
Patients were referred to the Immunology Centre
from many departments, including primary care and
surgical pre-operative assessment clinics. All patients
were interviewed by a Specialist Nurse andor doctor
using a structured questionnaire, examining atopic
status, timing and nature of reactions, amount and
type of triggering allergen and reactions with latex
cross-reactive foods, and an estimate of pre-test prob-
ability of latex allergy was made from clinical experi-
ence.
All patients underwent total and latex-specific IgE
blood tests. Those with an appropriate history (urti-
caria, angioedema, rhinitis, wheeze, or anaphylaxis)
and a positive specific IgE result (>0.35 AUml) were
termed ‘latex allergic’ and counselled accordingly.
Those with a negative blood test and total IgE <100
kUL were skin tested.
In addition, 627 consecutive unselected latex-
specific IgE negative samples received by the labora-
tory were analysed to determine the effect of chang-
ing this cut-off on numbers of skin tests.
In-vitro TESTING
For in-vitro testing, we used an automated
fluoroenzymeimmunoassay- ImmunoCAP (uniCAP
250; Pharmacia Diagnostics, Uppsala, Sweden) to
measure total IgE levels and latex specific IgE (non-
ammoniated latex extract from Hevea brasiliensis-
specification, k82).
SKIN-PRICK TESTING
For skin prick test (SPT), we used Soluprick SQ
(non-ammoniated latex [NAL] extract) from ALK-
ABELLÓ at 3 concentrations 1, 10 and 100 HEP. Posi-
tive controls (histamine) and negative controls (albu-
min) were used. A plastic lancet of 2 mm depth was
used to puncture the surface of the skin after applica-
tion of the allergen. Readings were performed after
15 minutes of application. Skin wheal 3 mm was
taken as a positive result. The newly introduced am-
moniated latex (AL) skin testing solution was not
available at the time.
Data of total IgE, latex specific IgE and skin test re-
sults were collected. We analysed various cut-off lev-
els of total IgE in the context of negative latex specific
IgE and positive skin tests to determine a ‘safe’ cut-off
of total IgE for interpretation of negative latex-specific
IgE.
SDS-PAGE ON NAL AND AL SPT SOLUTIONS
18% SDS-PAGE pre-cast gel 8.6 × 6.8 cm and Trisgly-
cineSDS buffer were obtained from Bio-Rad Labora-
tories Ltd (Bio-Rad House, Hemel Hempstead, Hert-
fordshire, UK). TCEP-HCl was used to reduce the
100 HEP NAL solution and AL solution. The Mini-
PROTEAN 3 kit (Bio-Rad) was used for vertical pro-
tein electrophoresis. Different protein loading
strengths were used and three sets of experiments
were done to check for consistency of results. The
gel was run at 200 V for 35 minutes.
Modified silver stain protocol was used to stain the
protein bands as per manufacturer’s instructions.3
Briefly, the electrophoresed gel was treated with fixa-
tive [40% methanol10% acetic acid (vv) ] for a mini-
mum of 30 minutes, followed by staining with oxi-
diser (potassium dichromate and nitric acid, 10-fold
stock solution diluted) for 5 minutes. Large volumes
of water were used to flush the oxidiser from the gel
for a maximum of 15 minutes. This was followed by
treatment with silver reagent for 20 minutes, and a
quick water rinse of 30 seconds. Developer was then
added for 30 seconds and changed as soon as a pre-
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Fig. 1 18% SDS-PAGE gel photograph with molecular weight markers.
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cipitate was formed until a desired staining intensity
was obtained and further development stopped by ad-
dition of 5% acetic acid (vv). Manufacturer reported
sensitivity of protein intensity with this protocol was 1
ngband. A pre-stained SDS-PAGE molecular weight
standard was run at the same time.
This study was part of a service evaluation and all
investigations performed were part of standardized
testing procedures and skin testing were done with
patient consent. The Research & Development Com-
mittee of the Trust approved the study.
RESULTS
LATEX SPECIFIC IgE TEST WAS NOT SUFFI-
CIENTLY SENSITIVE WITH TOTAL IgE <100 kUL
Pre-assessment clinic identified the patients with
high pre-test probability of latex allergy who were of-
fered SPT. 51 had a total IgE <100 (range 2.8-99.0
kUL) with negative specific IgE were interviewed at
the Nurse-led clinic and SPT was done. The clinical
symptoms and skin test results are detailed in Table
1. Five of these 51 (10%) patients had a positive skin
test (3-5 mm), and total IgE ranged from 31-82 kUL.
20% (15) and 60% (35) of positive skin tests would
have been missed using total IgE cut-offs of 80 and 50
respectively; equating to 2% and 6% of referrals (Table
2).
INCREASING TOTAL IgE CUT-OFF INCREASED
SKIN TESTING WORKLOAD
Analysis on 627 consecutive negative latex specific
IgE samples showed an expected 40% increase in SPT
workload on increasing the total IgE cut-off from 50
to 100 kUL.
SDS-PAGE OF NAL SOLUTION HAD MORE
RELEVANT ALLERGENS DETECTABLE THAN
AL SOLUTION
SDS-PAGE of the NAL solution showed 3 prominent
bands with molecular weights (MW) of approxi-
mately 20, 24 and 42 kDa when compared with the
mobility of a standard range of 10 MW markers (Fig.
1). These correlated with the known Hevea brasilien-
sis allergens Hev b 6, Hev b 3 and Hev b 713, respec-
tively. Another 5 faint bands were also evident. In
contrast, the AL solution showed 3 very faint higher
molecular weights bands (63, 94 and 124 kDa) seen
also as faint bands in the NAL PAGE lane. These did
not correlate with the MW of the known clinically
relevant antigens (according to the IUIS Allergen No-
menclature Subcommittee).4
DISCUSSION
Our study showed that knowledge of total IgE levels
was significant in the context of negative specific IgE
in determining whether additional tests were re-
quired in patients with high pre-test probability of la-
tex allergy. Best practice guidelines do not recom-
mend routine total IgE testing in the diagnosis of al-
lergy, and allergen-specific IgE testing are recom-
mended based on the clinical indications.5 The inclu-
sion of international reference standards for total IgE
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in kits that are used to measure allergen-specific IgE
has enabled the expression of specific IgE quantita-
tively in international units rather than semi- quantita-
tively in scores.
We believe that total IgE levels are useful in the in-
terpretation of certain specific IgE tests, for example
in anaphylaxis, because they permit the ascertain-
ment of possible false-negative or false-positive re-
sults.6-8 It can be argued that the pre-test probability
of latex allergy in general is low and that would not
justify estimation of total IgE in all patients. However,
this study showed that an increase in the total IgE
cut-off limit from 50 kUL to 100 kUL led to an in-
crease in specific IgE sensitivity, a factor that is not
accounted for in most studies. We have adopted this
policy of skin testing patients with high probability of
latex allergy and negative specific IgE (total IgE <100
kUL) for over 5 years and have not had any referral
for serious reactions in those with negative specific
IgE and total IgE >100 kUL (Authors’ observations,
unpublished data). Total IgE level testing can there-
fore be recommended in the evaluation of predisposi-
tion to atopy, but further tests should be done in the
context of clinical symptoms and negative specific
IgE.
SDS-PAGE showed that the NAL SPT reagent con-
tained the major latex proteins. The AL SPT reagent
contained fewer proteins despite an identical protein
load on electrophoresis. Previous studies have high-
lighted this as a potential issue for the AL preparation
in comparison with others.9-11 Our observation may
be due to several factors: (1) loss of proteins during
processing of the AL reagent, which may result in in-
creased false negative SPT; (2) degradation of AL re-
agent more rapidly than NAL (but both were stored
under similar conditions); and (3) interference by AL
in the Bradford protein assay used to calculate the gel
protein load. However, the dilutions required, based
on the protein assay results, were similar for both
SPT reagents; and there were other technical prob-
lems (4) with the SDS-PAGE such as failure to re-
duce proteins during the reducing step, or agglutina-
tion of proteins in the AL reagent.
In conclusion, we feel that specific IgE testing is a
good screening test, providing the total IgE is high
enough to make the assay sufficiently sensitive. SPT
alone may not be sufficient particularly with the
newer reagents and challenge testing remains a pos-
sibility in certain cases. Estimation of pre-test prob-
ability in all cases of allergy is critical and influences
the choice and combinations of tests used.
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